Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Stavas

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Pediatrics|April 29, 2011
β-blockers for infantile hemangiomas: a single-institution experienceJulie Blatt, Dean S Morrell, Scott Buck, et al.
Kidney International Reports|July 11, 2022
Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker AnalysisJoseph Stavas, Guido Filler, Deepak Jain, et al.
Kidney International Reports|March 27, 2026
Corrigendum to "Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis" [<i>Kidney International Reports</i> Volume 7, Issue 7, July 2022, Pages 1619-1629]Joseph Stavas, Guido Filler, Deepak Jain, et al.
American Journal of Nephrology|January 16, 2022
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial DesignJoseph Stavas, David Gerber, Steven G Coca, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2026
A Randomized Clinical Trial of Kidney Autologous Cell Therapy in Diabetic Kidney DiseaseČižman Borut, Emily L Butler, Joseph Stavas, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Pediatrics|April 29, 2011
β-blockers for infantile hemangiomas: a single-institution experienceJulie Blatt, Dean S Morrell, Scott Buck, et al.
Kidney International Reports|July 11, 2022
Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker AnalysisJoseph Stavas, Guido Filler, Deepak Jain, et al.
Kidney International Reports|March 27, 2026
Corrigendum to "Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis" [<i>Kidney International Reports</i> Volume 7, Issue 7, July 2022, Pages 1619-1629]Joseph Stavas, Guido Filler, Deepak Jain, et al.
American Journal of Nephrology|January 16, 2022
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial DesignJoseph Stavas, David Gerber, Steven G Coca, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2026
A Randomized Clinical Trial of Kidney Autologous Cell Therapy in Diabetic Kidney DiseaseČižman Borut, Emily L Butler, Joseph Stavas, et al.
Pageof 2